{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:12:35Z","timestamp":1790194355960,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH092301"],"award-info":[{"award-number":["R01MH092301"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["K24MH102743"],"award-info":[{"award-number":["K24MH102743"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH110008"],"award-info":[{"award-number":["U01MH110008"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH092301"],"award-info":[{"award-number":["R01MH092301"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["K24MH102743"],"award-info":[{"award-number":["K24MH102743"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["U01MH110008"],"award-info":[{"award-number":["U01MH110008"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation plays a role in depression pathophysiology and treatment response, with effects varying by sex and therapeutic modality. Lower levels of interleukin(IL)-8 predict depression response to antidepressant medication and to electroconvulsive therapy (ECT), although ECT effects are specific to females. Whether IL-8 predicts depression response to ketamine and in a sex-specific manner is not known. Here, depressed patients (<jats:italic>n<\/jats:italic>\u2009=\u200946; female, <jats:italic>n<\/jats:italic>\u2009=\u200917) received open label infusion of ketamine (0.5\u2009mg\/kg over 40\u2009min; NCT02165449). Plasma levels of IL-8 were evaluated at baseline and post-treatment. Baseline levels of IL-8 had a trending association with response to ketamine, depending upon sex (responder status \u00d7 sex interaction: <jats:italic>p<\/jats:italic>\u2009=\u20090.096), in which lower baseline levels of IL-8 in females (<jats:italic>p<\/jats:italic>\u2009=\u20090.095) but not males (<jats:italic>p<\/jats:italic>\u2009=\u20090.96) trended with treatment response. Change in levels of IL-8 from baseline to post-treatment differed significantly by responder status (defined as \u226550% reduction in Hamilton Depression Rating Scale [HAM-D] Score), depending upon sex (responder status \u00d7 sex \u00d7 time interaction: <jats:italic>F<\/jats:italic>(1,42)=6.68, <jats:italic>p<\/jats:italic>\u2009=\u20090.01). In addition, change in IL-8 interacted with sex to predict change in HAM-D score (\u03b2\u2009=\u2009-0.63, <jats:italic>p<\/jats:italic>\u2009=\u20090.003); increasing IL-8 was associated with decreasing HAM-D score in females (<jats:italic>p<\/jats:italic>\u2009=\u20090.08) whereas the inverse was found in males (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Other inflammatory markers (IL-6, IL-10, tumor necrosis factor-\u03b1, C-reactive protein) were explored with no significant relationships identified. Given these preliminary findings, further evaluation of sex differences in the relationship between IL-8 and treatment response is warranted to elucidate mechanisms of response and aid in the development of personalized approaches to depression treatment.<\/jats:p>","DOI":"10.1038\/s41398-021-01268-z","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T09:05:22Z","timestamp":1615799122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0628-3921","authenticated-orcid":false,"given":"Jennifer L.","family":"Kruse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha M.","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Olmstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2449-7704","authenticated-orcid":false,"given":"Gerhard","family":"Hellemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Congdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-4212","authenticated-orcid":false,"given":"Randall","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Narr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1502-8431","authenticated-orcid":false,"given":"Michael R.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"1268_CR1","first-page":"1517","volume":"317","author":"MJ Friedrich","year":"2017","unstructured":"Friedrich, M. J. Depression is the leading cause of disability around the world. JAMA 317, 1517\u20131517 (2017).","journal-title":"JAMA"},{"key":"1268_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-90","volume":"9","author":"E Bromet","year":"2011","unstructured":"Bromet, E. et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 9, 90 (2011).","journal-title":"BMC Med."},{"key":"1268_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"1268_CR4","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno, D. et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol. Med. 39, 413\u2013423 (2009).","journal-title":"Psychol. Med."},{"key":"1268_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/gps.4250","volume":"30","author":"B Au","year":"2015","unstructured":"Au, B., Smith, K. J., Gariepy, G. & Schmitz, N. The longitudinal associations between C-reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA). Int. J. Geriatr. Psychiatry 30, 976\u2013984 (2015).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"1268_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg, A. et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 58, 445\u2013452 (2001).","journal-title":"Arch. Gen. Psychiatry"},{"key":"1268_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.biopsych.2010.06.010","volume":"68","author":"NI Eisenberger","year":"2010","unstructured":"Eisenberger, N. I. et al. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biol. Psychiatry 68, 748\u2013754 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1268_CR8","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/npp.2015.17","volume":"40","author":"M Moieni","year":"2015","unstructured":"Moieni, M. et al. Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 40, 1709\u20131716 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"1268_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron, L. et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26, 643\u2013652 (2002).","journal-title":"Neuropsychopharmacology"},{"key":"1268_CR10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso, S. et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 22, 86\u201390 (2002).","journal-title":"J. Clin. Psychopharmacol."},{"key":"1268_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati, Y. et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 67, 446\u2013457 (2010).","journal-title":"Biol. Psychiatry"},{"key":"1268_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H. & Kivimaki, M. Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain Behav. Immunol. 49, 206\u2013215 (2015).","journal-title":"Brain Behav. Immunol."},{"key":"1268_CR13","doi-asserted-by":"crossref","unstructured":"Moieni M., et al. Sex differences in the relationship between inflammation and reward sensitivity: a randomized controlled trial of endotoxin. Biol. Psychiatry: Cogn. Neurosci. Neuroimaging 4, 619\u2013626 (2019).","DOI":"10.1016\/j.bpsc.2019.03.010"},{"key":"1268_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.4088\/JCP.12r07694","volume":"73","author":"M Udina","year":"2012","unstructured":"Udina, M. et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J. Clin. Psychiatry 73, 1128\u20131138 (2012).","journal-title":"J. Clin. Psychiatry"},{"key":"1268_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","volume":"32","author":"T Eller","year":"2008","unstructured":"Eller, T., Vasar, V., Shlik, J. & Maron, E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 445\u2013450 (2008).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1268_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U. & Vedder, H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370\u2013379 (2000).","journal-title":"Neuropsychopharmacology"},{"key":"1268_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2011.07.239","volume":"26","author":"HH Chang","year":"2012","unstructured":"Chang, H. H. et al. Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav. Immun. 26, 90\u201395 (2012).","journal-title":"Brain Behav. Immun."},{"key":"1268_CR18","doi-asserted-by":"crossref","unstructured":"Uher, R. et al. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am. J. Psychiatry 171, 1278\u20131286 (2014).","DOI":"10.1176\/appi.ajp.2014.14010094"},{"key":"1268_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1089\/cap.2015.0147","volume":"26","author":"M Amitai","year":"2016","unstructured":"Amitai, M. et al. The relationship between plasma cytokine levels and response to selective serotonin reuptake inhibitor treatment in children and adolescents with depression and\/or anxiety disorders. J. Child Adolesc. Psychopharmacol. 26, 727\u2013732 (2016).","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"1268_CR20","doi-asserted-by":"crossref","unstructured":"Kruse, J. L., et al. Inflammation and improvement of depression following electroconvulsive therapy in treatment-resistant depression. J. Clin. Psychiatry 79, 17m11597 (2018).","DOI":"10.4088\/JCP.17m11597"},{"key":"1268_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jad.2019.06.040","volume":"256","author":"A Carlier","year":"2019","unstructured":"Carlier, A. et al. Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study\u2730. J. Affect. Disord. 256, 509\u2013516 (2019).","journal-title":"J. Affect. Disord."},{"key":"1268_CR22","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/npp.2013.71","volume":"38","author":"AK Walker","year":"2013","unstructured":"Walker, A. K. et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL\/6J mice. Neuropsychopharmacology 38, 1609\u20131616 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1268_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","volume":"16","author":"AH Miller","year":"2016","unstructured":"Miller, A. H. & Raison, C. L. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16, 22\u201334 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1268_CR24","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/j.biopsych.2014.06.021","volume":"77","author":"J-j Yang","year":"2015","unstructured":"Yang, J.-j et al. Serum interleukin-6 is a predictive biomarker for ketamine\u2019s antidepressant effect in treatment-resistant patients with major depression. Biol. Psychiatry 77, e19\u2013e20 (2015).","journal-title":"Biol. Psychiatry"},{"key":"1268_CR25","doi-asserted-by":"crossref","unstructured":"Machado-Vieira R., et al. The role of adipokines in the rapid antidepressant effects of ketamine. Mol. Psychiatry 22, 127\u2013133 (2016).","DOI":"10.1038\/mp.2016.36"},{"key":"1268_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.31","volume":"7","author":"DD Kiraly","year":"2017","unstructured":"Kiraly, D. D. et al. Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome. Transl. Psychiatry 7, e1065 (2017).","journal-title":"Transl. Psychiatry"},{"key":"1268_CR27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jpsychires.2016.09.025","volume":"84","author":"M Park","year":"2017","unstructured":"Park, M. et al. Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression. J. Psychiatr. Res. 84, 113\u2013118 (2017).","journal-title":"J. Psychiatr. Res."},{"key":"1268_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jpsychires.2019.03.013","volume":"113","author":"MK Jha","year":"2019","unstructured":"Jha, M. K. et al. Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study. J. Psychiatr. Res. 113, 165\u2013171 (2019).","journal-title":"J. Psychiatr. Res."},{"key":"1268_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2020.05.069","volume":"89","author":"JL Kruse","year":"2020","unstructured":"Kruse, J. L. et al. Inflammation and depression treatment response to electroconvulsive therapy: Sex-specific role of interleukin-8. Brain Behav. Immun. 89, 59\u201366 (2020).","journal-title":"Brain Behav. Immun."},{"key":"1268_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41386-018-0124-7","volume":"44","author":"JR Rainville","year":"2019","unstructured":"Rainville, J. R. & Hodes, G. E. Inflaming sex differences in mood disorders. Neuropsychopharmacology 44, 184\u2013199 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"1268_CR31","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nm.4386","volume":"23","author":"B Labonte","year":"2017","unstructured":"Labonte, B. et al. Sex-specific transcriptional signatures in human depression. Nat. Med. 23, 1102\u20131111 (2017).","journal-title":"Nat. Med."},{"key":"1268_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","volume":"62","author":"O Kohler-Forsberg","year":"2017","unstructured":"Kohler-Forsberg, O. et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav. Immun. 62, 344\u2013350 (2017).","journal-title":"Brain Behav. Immun."},{"key":"1268_CR33","doi-asserted-by":"crossref","unstructured":"Felger, J. C. et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol. Psychiatry 25, 1301\u20131311 (2018).","DOI":"10.1038\/s41380-018-0096-3"},{"key":"1268_CR34","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1182\/blood-2003-10-3380","volume":"104","author":"AK Bengtsson","year":"2004","unstructured":"Bengtsson, A. K., Ryan, E. J., Giordano, D., Magaletti, D. M. & Clark, E. A. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 104, 1404\u20131410 (2004).","journal-title":"Blood"},{"key":"1268_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1471-4159.2001.00469.x","volume":"78","author":"C Puma","year":"2001","unstructured":"Puma, C., Danik, M., Quirion, R., Ramon, F. & Williams, S. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 78, 960\u2013971 (2001).","journal-title":"J. Neurochem."},{"key":"1268_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0165-5728(98)00192-1","volume":"92","author":"A Giovannelli","year":"1998","unstructured":"Giovannelli, A. et al. CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92, 122\u2013132 (1998).","journal-title":"J. Neuroimmunol."},{"key":"1268_CR37","doi-asserted-by":"crossref","unstructured":"Saas, P., et al. A self-defence mechanism of astrocytes against Fas-mediated death involving interleukin-8 and CXCR2. Neuroreport 13, 1921\u20131924 (2002).","DOI":"10.1097\/00001756-200210280-00018"},{"key":"1268_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0006-8993(93)90400-H","volume":"600","author":"DM Araujo","year":"1993","unstructured":"Araujo, D. M. & Cotman, C. W. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600, 49\u201355 (1993).","journal-title":"Brain Res."},{"key":"1268_CR39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41380-019-0474-5","volume":"25","author":"JJ Liu","year":"2019","unstructured":"Liu, J. J. et al. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol. Psychiatry 25, 339\u2013350 (2019).","journal-title":"Mol. Psychiatry"},{"key":"1268_CR40","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/hbm.24895","volume":"41","author":"JRA Loureiro","year":"2020","unstructured":"Loureiro, J. R. A. et al. Modulation of amygdala reactivity following rapidly acting interventions for major depression. Hum. Brain Mapp. 41, 1699\u20131710 (2020).","journal-title":"Hum. Brain Mapp."},{"key":"1268_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.euroneuro.2020.01.017","volume":"33","author":"AK Sahib","year":"2020","unstructured":"Sahib, A. K. et al. Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder. Eur. Neuropsychopharmacol. 33, 89\u2013100 (2020).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1268_CR42","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jad.2015.11.018","volume":"190","author":"MM Vasavada","year":"2016","unstructured":"Vasavada, M. M. et al. Structural connectivity and response to ketamine therapy in major depression: a preliminary study. J. Affect. Disord. 190, 836\u2013841 (2016).","journal-title":"J. Affect. Disord."},{"key":"1268_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1268_CR44","unstructured":"Gelenberg, A. F. M., Markowitz, J. & Rosenbaum, J. Practice Guideline for the Treatment of Patients with Major Depressive Disorder (American Psychiatric Association, 2010)."},{"key":"1268_CR45","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1158\/1055-9965.EPI-13-0379","volume":"22","author":"MM Epstein","year":"2013","unstructured":"Epstein, M. M. et al. Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol. Biomark. Prev. 22, 2009\u20132015 (2013).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"1268_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neuropharm.2017.11.022","volume":"130","author":"AM Dossat","year":"2018","unstructured":"Dossat, A. M., Wright, K. N., Strong, C. E. & Kabbaj, M. Behavioral and biochemical sensitivity to low doses of ketamine: Influence of estrous cycle in C57BL\/6 mice. Neuropharmacology 130, 30\u201341 (2018).","journal-title":"Neuropharmacology"},{"key":"1268_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/srep21322","volume":"6","author":"SK Saland","year":"2016","unstructured":"Saland, S. K., Schoepfer, K. J. & Kabbaj, M. Hedonic sensitivity to low-dose ketamine is modulated by gonadal hormones in a sex-dependent manner. Sci. Rep. 6, 21322 (2016).","journal-title":"Sci. Rep."},{"key":"1268_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuropharm.2012.12.009","volume":"70","author":"N Carrier","year":"2013","unstructured":"Carrier, N. & Kabbaj, M. Sex differences in the antidepressant-like effects of ketamine. Neuropharmacology 70, 27\u201334 (2013).","journal-title":"Neuropharmacology"},{"key":"1268_CR49","unstructured":"International Standard Classification of Education (ISCED). Montreal, Canada, UNESCO Institute for Statistics (2012). http:\/\/uis.unesco.org\/sites\/default\/files\/documents\/international-standard-classification-of-education-isced-2011-en.pdf."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01268-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01268-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01268-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T15:31:03Z","timestamp":1669822263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01268-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1268"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01268-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"167"}}